Loading chat...

WV HB4721

Bill

Official Source

Status

Introduced

1/22/2026

Primary Sponsor

Rick Hillenbrand

Click for details

Origin

House of Delegates

2026 Regular Session

AI Summary

  • Amends West Virginia Code §60A-2-204 (Schedule I controlled substances) to create an exception for FDA-approved crystalline polymorph psilocybin
  • Crystalline polymorph psilocybin would be removed from Schedule I status if approved by both the Food and Drug Administration and the Drug Enforcement Administration
  • Psilocybin in non-crystalline polymorph forms would remain classified as a Schedule I hallucinogenic substance under state law
  • Introduced January 22, 2026, by Delegates Hillenbrand and Worrell and referred to the Health and Human Resources Committee and then the Judiciary Committee

Legislative Description

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Health

Last Action

To House Health and Human Resources

1/22/2026

Committee Referrals

Health & Human Resources1/22/2026

Full Bill Text

No bill text available